Myles McNulty Avacta People don’t appreciate the potential cost/profit of this drug. Keytruda is £84000 per patient .Dox/many chemo are off patent so are cheap.Avacta drugs won’t be . Chemo is still one of the most efficient drugs there is. Make it safe and it’s a cancer game changer, beyond exciting
💙jacque-blue💙is gonna Build Back Better 💪💗 Thanks Cancer! Keytruda saved my life along with MassGeneral Medicine
Building your own #SmallBusiness website is easy with today’s tools. Tips from expert Adesina Sanchez will help you make your DIY site look polished and professional.
Read her advice at #MagentaEdge : t-mo.co/422XAo0
Nick Hargrave RAH Stephen Casey andrewsentance What about the price of treatment?. Keytruda world's leading cancer drug revenue I believe for Merke.$5.8 bio a 1/4.Uk £84000 per treatment.Dox off-patent is as cheap as chips. I wonder where they will price it?
Excited to finally share that Keynote 811 survival data in first line HER2+ gastroesophageal cancer will be presented at ESMO - Eur. Oncology Memorial Sloan Kettering Cancer Center MSK Department of Medicine
businesswire.com/news/home/2023…